Kiadis shares yo-yo on cell therapy trial for COVID-19
Billionaire Steven Cohen Pulls the Trigger on These 3 Penny Stocks
Novavax Launches Covid-19 Vaccine Efficacy Trial In South Africa
EU places firm order for AZ/Oxford Uni’s ChAdOx1 COVID-19 vaccine
Goldman Sachs: These 3 Stocks Can Deliver Big Returns for Investors
Novavax Pops 7% On South Korea Deal For Global Covid-19 Vaccine Supply
Study shows frequently used serology test may not detect antibodies that could confirm protection against reinfection of COVID-19
Sinopharm’s potential Covid-19 vaccine triggers antibodies in clinical trials
Novavax Inks UK Supply Deal For 60M Doses Of Its Covid-19 Vaccine Candidate
UK signs coronavirus vaccine deals with J&J and Novavax
Coronavirus pharma news roundup – 14/08/20
COVID-19 and pregnancy: what we know about what happens to your immune system
China Sinopharm’s potential COVID-19 vaccine triggers antibodies in clinical trials: journal
New tools catch and release molecules at the flip of a light switch
Novavax ties up with SK bioscience to boost supply of potential COVID-19 vaccine
America's Obesity Epidemic Threatens Effectiveness of Any COVID Vaccine
Around 3.4m people infected with coronavirus in England – study
Dear 'Younger Generations', "Don't Live Your Life In A Bubble"
Covid-19 roundup: Researchers call out Gilead for diversity of remdesivir trials in NEJM; Mexico in vaccine dose, trial talks
Malaria Treatment May Be Found by Targeting the Host
Coronavirus: does the common cold protect you from COVID?
Inovio To Start Phase 2/3 Study Of Covid-19 Candidate In Sept.; Shares Drop 8%
I'm a COVID-19 long-hauler and an epidemiologist – here's how it feels when symptoms last for months
U.S. COVID-19 deaths drop for first time in four weeks
COVID-19 Prevention Network launches two research studies evaluating monoclonal antibodies
Agtech to the rescue in a pandemic: adapting plant labs for human testing
First patients in NIH ACTIV-3 clinical trial enroll in Dallas
Novavax Inks Vaccine Deals In Japan, India; Analyst Sees 70% Stock Upside
2 Top Coronavirus Stocks with Massive Upside Potential
Biotech Bonanza – Second Half Outlook 2020